Home » Topics » Regulatory

Regulatory
RSS

Ajinomoto and Dainippon granted approval for additional indication for Niflec and Gasmotin

April 27, 2009

European Commission approves Removab for malignant ascites

April 24, 2009

Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis

April 14, 2009

FDA approves Afinitor in patients with advanced kidney cancer

March 31, 2009

Additional indication for Actos approved in Japan

March 26, 2009

Fablyn approved in Europe for the treatment of osteoporosis

March 26, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

FDA approves expanded indication for peginterferon-based combination therapy

March 13, 2009

Mepact receives E.U. approval for non-metastatic resectable osteosarcoma

March 11, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026